Rocket Pharmaceuticals Gene Therapy Investor Deck

Rocket Pharmaceuticals presents its investor deck detailing development of first-in-class and best-in-class curative gene therapies for severe genetic diseases including Fanconi Anemia, Leukocyte Adhesion Deficiency-I, Pyruvate Kinase Deficiency, and Danon Disease. The presentation outlines the company's pipeline, clinical trial progress, and strategic approach to gene therapy innovation.